State-of-the-Art on Basic and Applied Stem Cell Therapy; Stem Cell Research Italy–International Society for Cellular Therapy Europe, Joint Meeting, Montesilvano (PE)–Italy, June 10–12, 2011

Citations Over TimeTop 25% of 2011 papers

Abstract

Over 160 stem cell-based therapeutic products are undergoing development for the treatment of several diseases, ranging from cardiac and artery diseases to immune and neurodegenerative pathologies, including diabetes, spinal cord injury. Therefore, stem cell therapy plays a key role for developing new cell-based drugs for the future molecular and regenerative medicine. The second meeting organized by Stem Cell Research Italy (SCR Italy) and by the International Society for Cellular Therapy-Europe (ISCT) in Montesilvano/Città S. Angelo (Pescara)-Italy, on June 10th-12th, 2011, focused on the state-of-the-art of stem cell therapy and associated novel findings on stem cell research ( www.stemcellitaly.org ).

Related Papers

• → Bioprinting in Regenerative Medicine(2016)17 cited
• → Advances in stem cells and regenerative medicine: single-cell dynamics, new models and translational perspectives(2017)5 cited
• → Current Trends in the Use of Cell Therapy in Regenerative Medicine(2020)2 cited
• Skin stem cell: its biology and application(2005)
• Adipose Stem cell for Aesthetic(2016)